AAPL   329.88 (+2.35%)
MSFT   186.36 (+1.88%)
FB   231.11 (+2.13%)
AMZN   2,478.02 (+0.71%)
CGC   16.77 (+0.84%)
BABA   219.83 (+0.82%)
GE   8.10 (+4.65%)
TSLA   877.81 (+1.55%)
AMD   53.37 (+1.41%)
T   32.80 (+3.15%)
F   7.27 (+10.66%)
BAC   28.36 (+5.90%)
BA   212.32 (+15.20%)
AAPL   329.88 (+2.35%)
MSFT   186.36 (+1.88%)
FB   231.11 (+2.13%)
AMZN   2,478.02 (+0.71%)
CGC   16.77 (+0.84%)
BABA   219.83 (+0.82%)
GE   8.10 (+4.65%)
TSLA   877.81 (+1.55%)
AMD   53.37 (+1.41%)
T   32.80 (+3.15%)
F   7.27 (+10.66%)
BAC   28.36 (+5.90%)
BA   212.32 (+15.20%)
AAPL   329.88 (+2.35%)
MSFT   186.36 (+1.88%)
FB   231.11 (+2.13%)
AMZN   2,478.02 (+0.71%)
CGC   16.77 (+0.84%)
BABA   219.83 (+0.82%)
GE   8.10 (+4.65%)
TSLA   877.81 (+1.55%)
AMD   53.37 (+1.41%)
T   32.80 (+3.15%)
F   7.27 (+10.66%)
BAC   28.36 (+5.90%)
BA   212.32 (+15.20%)
AAPL   329.88 (+2.35%)
MSFT   186.36 (+1.88%)
FB   231.11 (+2.13%)
AMZN   2,478.02 (+0.71%)
CGC   16.77 (+0.84%)
BABA   219.83 (+0.82%)
GE   8.10 (+4.65%)
TSLA   877.81 (+1.55%)
AMD   53.37 (+1.41%)
T   32.80 (+3.15%)
F   7.27 (+10.66%)
BAC   28.36 (+5.90%)
BA   212.32 (+15.20%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Innovate BiopharmaceuticalsNovanProvectus BiopharmaceuticalsEdesa BiotechSeelos Therapeutics
SymbolNASDAQ:INNTNASDAQ:NOVNOTCMKTS:PVCTNASDAQ:EDSANASDAQ:SEEL
Price Information
Current Price$0.58$0.46$0.04$3.19$1.12
52 Week RangeBuyBuyN/ABuyBuy
Beat the Market™ Rank
Overall Score0.61.20.61.61.4
Analysis Score0.03.30.00.03.5
Community Score2.42.23.02.52.8
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.04.00.0
Earnings & Valuation Score0.60.60.01.30.6
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyBuy
Consensus Price Target$10.00$1.00N/A$10.00$5.33
% Upside from Price Target1,624.14% upside115.15% upsideN/A213.48% upside376.19% upside
Trade Information
Market Cap$23.97 million$34.05 million$17.66 million$28.53 million$50.34 million
Beta-0.39-0.270.40.21.86
Average Volume525,9827,621,904231,66750,3702,105,474
Sales & Book Value
Annual RevenueN/A$4.90 millionN/A$210,000.00$380,000.00
Price / SalesN/A7.16N/A134.59132.48
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.27) per share($0.89) per share($0.06) per share$12.69 per shareN/A
Price / BookN/A-0.52N/A0.25
Profitability
Net Income$-27,050,000.00$-30,640,000.00$-6,920,000.00$-5,030,000.00$-51,260,000.00
EPSN/A($0.80)N/AN/AN/A
Trailing P/E RatioN/AN/A0.00N/A0.00
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-594.59%N/A-766.98%N/A
Return on Equity (ROE)N/AN/AN/A-83.42%-373.33%
Return on Assets (ROA)-234.42%-53.34%-448.70%-72.66%-159.01%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current Ratio0.35%1.99%0.13%12.83%1.97%
Quick Ratio0.35%1.99%0.13%12.83%1.97%
Ownership Information
Institutional Ownership Percentage5.88%23.06%0.03%0.05%11.53%
Insider Ownership Percentage7.90%5.36%4.50%61.40%7.60%
Miscellaneous
Employees84726N/A
Shares Outstanding41.33 million75.47 million390.69 million8.86 million44.95 million
Next Earnings DateN/A8/11/2020 (Estimated)8/13/2020 (Estimated)8/12/2020 (Estimated)8/6/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.